Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on the Pharmacokinetics of LY4395089 in Healthy Participants
NCT07592572Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of LY4395089 (3 arms), sponsored by Eli Lilly and Company. Primary endpoints: Area Under the Concentration versus Time Curve from 0 to infinity and Maximum Concentration. Started May 2026; status: completed.
02
Drugs
LY4395089
Beyond the preview
Go deeper on NCT07592572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07592572.